Time-restricted ketogenic diet in amyotrophic lateral sclerosis: a case study
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disorder. The most devastating variant is bulbar-onset ALS, which portends a median survival of 24 months from the onset of symptoms. Abundant evidence indicates that neuron metabolism and mitochondrial function are impaired in AL...
Main Authors: | Matthew C. L. Phillips, Samuel E. Johnston, Pat Simpson, David K. Chang, Danielle Mather, Rognvald J. Dick |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2023.1329541/full |
Similar Items
-
The Cell Autonomous and Non-Cell Autonomous Aspects of Neuronal Vulnerability and Resilience in Amyotrophic Lateral Sclerosis
by: Christoph Schweingruber, et al.
Published: (2022-08-01) -
Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship
by: Niccolò Candelise, et al.
Published: (2022-03-01) -
Pathophysiology of ion channels in amyotrophic lateral sclerosis
by: Robin N. Stringer, et al.
Published: (2023-12-01) -
Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis
by: Emanuele D’Amico, et al.
Published: (2021-06-01) -
Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis
by: Teresa Cunha-Oliveira, et al.
Published: (2024-01-01)